熔点 | 151.0-154.0°C |
应用 | It was used in the synthesis of mono and 2,3-disubstituted quinoxalines. It was used in solid phase synthesis of HPLC chiral stationary phase containing the N,N′-dialkyl-2,3-diaminoquinoxaline group as a linking structure. |
产品介绍 | It reacts with 6-aminothiouracil in ethanol/TEA to form 6-amino-2-(3-chloroquinoxalin-2-ylthio)pyrimidin-4(3H)-one. It reacts with cholest-5-en-3-one semicarbazone/thiosemicarbazone to form steriodal cholest-5-en-3-oxazolo and thiazoloquinoxaline. |
别名 | ; |
2,3-二氯喹喔啉
2,3-Dichloroquinoxaline (订货以英文为准)
编号:D123530
CAS号:2213-63-0
分子式:C8H4CL2N2
分子量:199.04
产品名称 | 2,3-Dichloroquinoxaline |
中文名称 | 2,3-二氯喹喔啉 |
CAS号 | 2213-63-0 |
MDL编码 | MFCD00006720 |
分子式(M.F.) | C8H4CL2N2 |
分子量(M.W.) | 199.04 |
Reaxys-RN | 3832668 |
技术规格
Background: | This gene is a member of the Ig superfamily and encodes a cell surface sialoglycoprotein expressed by cytokine-activated endothelium. This type I membrane protein mediates leukocyte-endothelial cell adhesion and signal transduction, and may play a role in the development of artherosclerosis and rheumatoid arthritis. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. |
Applications: | ELISA, IHC |
Name of antibody: | VCAM1 |
Immunogen: | Fusion protein of human VCAM1 |
Full name: | vascular cell adhesion molecule 1 |
Synonyms: | CD106; INCAM-100 |
SwissProt: | P19320 |
ELISA Recommended dilution: | 2000-5000 |
IHC positive control: | Human liver cancer and human esophagus cancer |
IHC Recommend dilution: | 25-100 |
搜索质检报告(COA)
搜索MSDS
相关产品